Korsgaard Frederik, Hasenkam John Michael, Vesterby Martin
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Health Serv Manage Res. 2021 Nov;34(4):223-233. doi: 10.1177/0951484820988628. Epub 2021 Jan 28.
The struggle to transform telemedicine from project level to daily clinical practice is ongoing. An assessment of the business models of telemedicine applications could provide insights into how to facilitate this transition. Our aim was to identify the qualitative characteristics of business models of long-term operational telemedicine providers in Denmark.A structured interview study design was applied to interviews of representatives from seven Danish companies providing home telemonitoring in long-term operation. Data was analysed using Osterwalder's Business Model Canvas framework.Multiple themes emphasized the importance of strong personal relationships between company representatives and healthcare providers. Personal relations could 1) secure a strong relationship to lead users and clinical ambassadors; 2) facilitate work with healthcare providers to develop, test and revise value propositions; 3) promote user support and education; 4) establish an indirect connection between companies and healthcare managers or decision makers.Thus, a strong personal relationship between company representatives and healthcare providers is of paramount importance when integrating home telemonitoring from project stage into clinical practice. However, this strategy could lack patient involvement, use of data, and business scalability. Additionally, companies with the ability to establish strong personal connections could be favoured over companies which provide strong clinical and economic evidence.
将远程医疗从项目层面转变为日常临床实践的努力仍在继续。对远程医疗应用商业模式的评估可以为如何促进这一转变提供见解。我们的目的是确定丹麦长期运营的远程医疗服务提供商商业模式的定性特征。采用结构化访谈研究设计,对丹麦七家长期提供家庭远程监测服务的公司的代表进行访谈。使用奥斯特瓦尔德的商业模式画布框架对数据进行分析。多个主题强调了公司代表与医疗服务提供者之间牢固个人关系的重要性。个人关系可以:1)确保与领先用户和临床大使建立牢固关系;2)促进与医疗服务提供者合作,以开发、测试和修订价值主张;3)促进用户支持和教育;4)在公司与医疗管理人员或决策者之间建立间接联系。因此,在将家庭远程监测从项目阶段整合到临床实践中时,公司代表与医疗服务提供者之间牢固的个人关系至关重要。然而,这种策略可能缺乏患者参与、数据使用和业务可扩展性。此外,能够建立牢固个人联系的公司可能比提供有力临床和经济证据的公司更受青睐。